Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 38 Breast Neoplasms 31 Lung Neoplasms 25 Colorectal Neoplasms 15 Prostatic Neoplasms 13 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Head and Neck Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Sarcoma 8 Colonic Neoplasms 8 Uterine Cervical Neoplasms 7 Melanoma 7 Glioma 7 Esophageal Neoplasms 7 Carcinoma, Hepatocellular 7 Lymphoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Neoplastic Cells, Circulating 5 Multiple Myeloma 5 Endometrial Neoplasms 5 Brain Neoplasms 5 Neoplasm, Residual 4 Gastrointestinal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma 4 Thrombosis 3 Skin Neoplasms 3

Interventions

Doxorubicin 4 pembrolizumab 3 Specimen Handling 3 toripalimab 2 Ifosfamide 2 Biopsy 2 silmitasertib 1 selinexor 1 peposertib 1 pemigatinib 1 pazopanib 1 palbociclib 1 mirdametinib 1 liposomal doxorubicin 1 abemaciclib 1 X-Rays 1 Vincristine 1 Trabectedin 1 Temozolomide 1 Surgical Procedures, Operative 1 Radiotherapy 1 Quality of Life 1 Proton Therapy 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Injections 1 Histamine H2 Antagonists 1 Gemcitabine 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liposarcoma × Blood Specimen Collection × Clear all

NCT04224064 2025-02-12

ESPACE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Liposarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡